Home » Topics » BioWorld Science

BioWorld Science
RSS

Pfizer synthesizes IL-2 production inhibitors

July 14, 2022

Merck & Co. discloses new DNA polymerase inhibitors

July 14, 2022

UCB SA patents DRD1 PAMs

July 14, 2022

Novel genetic polymorphism associated with macroangiopathy risk

July 14, 2022

FVIII-QQ gene transfer therapy shows advantage for treating hemophilia A

July 14, 2022

Novel genetic loci found for venous thromboembolism

July 13, 2022

"Master sites" trigger cascade of tau phosphorylation in Alzheimer's disease

July 13, 2022

Targeting IL-33 release may be an approach for treating HCC

July 13, 2022

Co-targeting MAPK and YAP-TEAD signaling as therapeutic strategy in melanoma

July 13, 2022

Royal College of Surgeons in Ireland discloses HDAC6 inhibitors

July 13, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...